Journal article
Anti-TNF therapy
- Abstract:
- Tumor necrosis factor (TNF) is one of the most important cytokines produced by macrophages. TNF is a very important component of host defense, released very rapidly after all types of injuries and stimuli. The kinetics of TNF release are short, and so it is perhaps not surprising that prolonged TNF production is associated with pathology. This was first elucidated in rheumatoid arthritis but extends to other chronic inflammatory diseases such as Crohn’s disease and psoriasis. In this chapter, the discovery of anti-TNF therapy is reviewed, with its benefit but also its limitations. The potential of anti-TNF therapy in other diseases, e.g., cardiovascular and fibrosis, is discussed, as is the opportunity to define ways of blocking TNF synthesis.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 940.2KB, Terms of use)
-
- Publisher copy:
- 10.1128/microbiolspec.MCHD-0022-2015
Authors
- Publisher:
- American Society for Microbiology
- Journal:
- Microbiology Spectrum More from this journal
- Volume:
- 4
- Issue:
- 4
- Article number:
- 46
- Publication date:
- 2016-08-12
- Acceptance date:
- 2015-10-26
- DOI:
- EISSN:
-
2165-0497
- Language:
-
English
- Pubs id:
-
pubs:653569
- UUID:
-
uuid:403abd11-9ec7-4e00-b581-204d1cbfde90
- Local pid:
-
pubs:653569
- Source identifiers:
-
653569
- Deposit date:
-
2017-01-17
- ARK identifier:
Terms of use
- Copyright holder:
- American Society for Microbiology
- Copyright date:
- 2016
- Rights statement:
- © 2016 American Society for Microbiology. All rights reserved.
- Notes:
-
This is the accepted manuscript version of the article. The final version is available from American Society for Microbiology at https://doi.org/10.1128/microbiolspec.MCHD-0022-2015
If you are the owner of this record, you can report an update to it here: Report update to this record